NO951421L - Fremgangsmåte til fremstilling av rent podofyllotoksin - Google Patents
Fremgangsmåte til fremstilling av rent podofyllotoksinInfo
- Publication number
- NO951421L NO951421L NO951421A NO951421A NO951421L NO 951421 L NO951421 L NO 951421L NO 951421 A NO951421 A NO 951421A NO 951421 A NO951421 A NO 951421A NO 951421 L NO951421 L NO 951421L
- Authority
- NO
- Norway
- Prior art keywords
- podophyllotoxin
- solvent
- drying
- crystals
- maximum
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
En fremgangsmåte til fremstilling av krystalinsk, vannfri podofyllotoksinforbindelse (1) fra et podo-fyllotoksinprodukt som omfatter å oppløse produk-tet i et ikke-aromatisk og ikke-halogenert oppløs-ningsmiddel som har et kokepunkt ved atmosfære-trykk som ikke overskrider 130°C og som inneholder maksimalt ca 1 volum% vann, avkjøling av oppløsningen for å utfelle krystaller av podofyllo-toksin, isolering av krystallene og tørking av dem ved en temperatur som under tørkeprosedyren blir. øket, men er alltid slik at den er lavere enn tempe-raturen på hvilken krystallene sintrer eller smelter, hvor tørkingen blir fortsatt inntil smeltepunktet er i et område på 183-184°C og restmengden av oppløs-ningsmiddelet er maksimalt 500 ppm. Når utgangs-materialet inneholder komplekst eller adsorbert organsik oppløsningsmiddel, blir en initiell aseotro-pisk inndampingsbehandling foretatt for å fjerne dette oppløsningsmiddel. Utbytte av rent podofyllo-toksin er i stor grad øket ved tilsetting av vann til krystallisasjonsblandingen.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/960,102 US5315016A (en) | 1992-10-13 | 1992-10-13 | Process for preparing pure podophyllotoxin |
PCT/DK1993/000313 WO1994009008A1 (en) | 1992-10-13 | 1993-09-29 | Process for preparing pure podophyllotoxin |
Publications (2)
Publication Number | Publication Date |
---|---|
NO951421L true NO951421L (no) | 1995-04-11 |
NO951421D0 NO951421D0 (no) | 1995-04-11 |
Family
ID=25502797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO951421A NO951421D0 (no) | 1992-10-13 | 1995-04-11 | Fremgangsmåte til fremstilling av rent podofyllotoksin |
Country Status (10)
Country | Link |
---|---|
US (1) | US5315016A (no) |
EP (1) | EP0664809A1 (no) |
JP (1) | JPH08500840A (no) |
CN (1) | CN1099031A (no) |
AU (1) | AU5108293A (no) |
CA (1) | CA2144956A1 (no) |
FI (1) | FI951723A (no) |
NO (1) | NO951421D0 (no) |
WO (1) | WO1994009008A1 (no) |
ZA (1) | ZA937165B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2449419C (en) | 1994-05-18 | 2011-09-06 | Aventis Pharmaceuticals Inc. | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
CN102686594A (zh) * | 2009-12-16 | 2012-09-19 | 熙德隆研究基金会 | 地瑞那韦的多晶型物 |
EP2571355B1 (en) | 2010-05-20 | 2016-09-07 | Hetero Research Foundation | Crystalline hydrochloride salt of darunavir |
CN104098583B (zh) * | 2013-04-09 | 2018-02-02 | 中国医学科学院药物研究所 | 鬼臼毒素晶x型物质及制备方法和其药物组合物与用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0316964B1 (en) * | 1984-09-26 | 1991-05-29 | pHarma-medica a-s | Process for the purification of podophyllotoxin |
GB8424269D0 (en) * | 1984-09-26 | 1984-10-31 | Pharma Medica As | Isolation and purification of podophyllotoxin |
US5057616A (en) * | 1989-09-29 | 1991-10-15 | Oclassen Pharmaceuticals, Inc. | Podophyllotoxin purification process |
-
1992
- 1992-10-13 US US07/960,102 patent/US5315016A/en not_active Expired - Fee Related
-
1993
- 1993-09-27 ZA ZA937165A patent/ZA937165B/xx unknown
- 1993-09-29 WO PCT/DK1993/000313 patent/WO1994009008A1/en not_active Application Discontinuation
- 1993-09-29 CA CA002144956A patent/CA2144956A1/en not_active Abandoned
- 1993-09-29 AU AU51082/93A patent/AU5108293A/en not_active Abandoned
- 1993-09-29 JP JP6509520A patent/JPH08500840A/ja active Pending
- 1993-09-29 EP EP93921834A patent/EP0664809A1/en not_active Withdrawn
- 1993-10-13 CN CN93114855A patent/CN1099031A/zh active Pending
-
1995
- 1995-04-11 NO NO951421A patent/NO951421D0/no unknown
- 1995-04-11 FI FI951723A patent/FI951723A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US5315016A (en) | 1994-05-24 |
AU5108293A (en) | 1994-05-09 |
FI951723A0 (fi) | 1995-04-11 |
CA2144956A1 (en) | 1994-04-28 |
FI951723A (fi) | 1995-04-11 |
ZA937165B (en) | 1994-05-18 |
EP0664809A1 (en) | 1995-08-02 |
WO1994009008A1 (en) | 1994-04-28 |
JPH08500840A (ja) | 1996-01-30 |
NO951421D0 (no) | 1995-04-11 |
CN1099031A (zh) | 1995-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4873330A (en) | A process for the preparation of anhydrous, stable, crystalline delta-form of prazosin hydrochloride | |
US5310934A (en) | Process for purifying phthalimidoperoxycaproic acid (PAP) in order to remove chlorinated solvent impurities from it | |
KR20070105299A (ko) | 레트로졸의 제조를 위한 개선된 방법 | |
US3823226A (en) | Preparation of aluminum hydride compositions | |
NO951421L (no) | Fremgangsmåte til fremstilling av rent podofyllotoksin | |
Webster et al. | Preparation and Purification of Methyl Borate and Ethyl Borate1 | |
JPS5527117A (en) | Preparation of isopropenylphenol | |
US3794647A (en) | Process for purifying lactams | |
US4438081A (en) | Process for the purification of cyclic chlorophosphazenes | |
Evers et al. | The interaction of boron halides with silyl cyanides | |
JP2936949B2 (ja) | N−メチル−2−ピロリドンの精製方法 | |
JPS5940838B2 (ja) | エチルバナデ−トの改良製造方法 | |
Burakevich et al. | Phenylfurazan oxide. Chemistry | |
US2917537A (en) | Its esters | |
C-CN | Studies on Succinic Acids V. The Preparation and Properties of Diastereoisomers of Tetraalkylsuccinic Acids | |
JPS5914462B2 (ja) | シアヌ−ル酸の精製法 | |
JPS6193165A (ja) | キナルジンの分離精製法 | |
JPH0437066B2 (no) | ||
US4758662A (en) | Purification of caffeine | |
US2777847A (en) | Products | |
Emeleus et al. | Preparation of arsenic tristrifluoroacetate and oxyfluoride | |
SU968030A1 (ru) | Способ очистки 2-меркаптопропиламина или его хлоргидрата | |
US3047564A (en) | Purification of impure x-aminolactams | |
US4866191A (en) | Stabilization of amine alanes | |
CA1039750A (en) | PROCESS FOR THE PREPARATION OF .alpha.-DIOL-.gamma.-DIOXO COMPOUNDS |